Search research articles
Contact Us
Filters
Showing results (481-490 of 517) with videos related to
Page
of 52
Sort By:
Organic & Biomolecular Chemistry
|
August 14, 2014
Iridium-catalyzed C-H borylation of pyridines
Scott A Sadler, Hazmi Tajuddin, Ibraheem A I Mkhalid, et al.
Journal of Patient Safety
|
March 18, 2021
Transmitting Device Identifiers of Implants From the Point of Care to Insurers: A Demonstration Project
Dan C Krupka, Jove Graham, Natalia A Wilson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 10, 2015
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy
Jose López-Torrecilla, Anna Boladeras, María Angeles Cabeza, et al.
Oncogene
|
April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Guilian Niu, Kenneth L Wright, Mei Huang, et al.
New Microbes and New Infections
|
July 4, 2025
Oropouche Fever in Beni, Bolivia, 2024
Juan Pablo Escalera-Antezana, Rodrigo Daniel Montesinos-Jove, Carlos Eduardo Gonzales-Flores, et al.
Nature Biotechnology
|
September 15, 2009
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann, et al.
The American Journal of Managed Care
|
August 18, 2010
Value and the medical home: effects of transformed primary care
Richard J Gilfillan, Janet Tomcavage, Meredith B Rosenthal, et al.
Cancer Cell
|
May 26, 2012
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites
Jiehui Deng, Yong Liu, Heehyoung Lee, et al.
Molecular Cancer Therapeutics
|
October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer
Wei Wen, Wei Liang, Jun Wu, et al.
Journal of the American Pharmacists Association : Japha
|
January 19, 2019
Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up
Eric A Wright, Jove H Graham, Daniel Maeng, et al.
Page
of 52
Search research articles
Search
Showing results (481-490 of 517) with videos related to
Sort By:
Page
of 52
Organic & Biomolecular Chemistry
|
August 14, 2014
Iridium-catalyzed C-H borylation of pyridines
Scott A Sadler, Hazmi Tajuddin, Ibraheem A I Mkhalid, et al.
Journal of Patient Safety
|
March 18, 2021
Transmitting Device Identifiers of Implants From the Point of Care to Insurers: A Demonstration Project
Dan C Krupka, Jove Graham, Natalia A Wilson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 10, 2015
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy
Jose López-Torrecilla, Anna Boladeras, María Angeles Cabeza, et al.
Oncogene
|
April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Guilian Niu, Kenneth L Wright, Mei Huang, et al.
New Microbes and New Infections
|
July 4, 2025
Oropouche Fever in Beni, Bolivia, 2024
Juan Pablo Escalera-Antezana, Rodrigo Daniel Montesinos-Jove, Carlos Eduardo Gonzales-Flores, et al.
Nature Biotechnology
|
September 15, 2009
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann, et al.
The American Journal of Managed Care
|
August 18, 2010
Value and the medical home: effects of transformed primary care
Richard J Gilfillan, Janet Tomcavage, Meredith B Rosenthal, et al.
Cancer Cell
|
May 26, 2012
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites
Jiehui Deng, Yong Liu, Heehyoung Lee, et al.
Molecular Cancer Therapeutics
|
October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer
Wei Wen, Wei Liang, Jun Wu, et al.
Journal of the American Pharmacists Association : Japha
|
January 19, 2019
Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up
Eric A Wright, Jove H Graham, Daniel Maeng, et al.
Page
of 52